We are live on ! Find out more
OPXAW

Opexa Therapeutics, Inc.
OPXAW

Delisted

OPXAW was delisted on the 20th of September, 2017.

Back to rankings

4 hedge funds and large institutions have $48K invested in Opexa Therapeutics, Inc. in 2016 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

20% less funds holding

Funds holding: 5 → 4 (-1)

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

65% less capital invested

Capital invested by funds: $137K → $48K (-$89K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
4
Holders Change
-1
Holders Change %
-20%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VKH
Virtu KCG Holdings
New York
+$2.43K

Top Sellers

Rank Fund Capital Flow
1
EEG
E.E. Geduld
-$4K
2
SM
Sabby Management
Florida
-$2K
3
UBS Group
UBS Group
Switzerland
-$242
Name Holding Trade Value Shares
Change 		Change in
Stake
Millennium Management
1
Millennium Management
New York
$40K – – –
California Public Employees Retirement System
2
California Public Employees Retirement System
California
$7K – – –
VKH
3
Virtu KCG Holdings
New York
$1K +$2.43K +36,792 New
EEG
4
E.E. Geduld
– -$4K -60,200 Closed
SM
5
Sabby Management
Florida
– -$2K -34,097 Closed
UBS Group
6
UBS Group
Switzerland
– -$242 -3,661 -90%

OPXAW Hedge Fund Activity: Q2 2016 in Review

4 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Opexa Therapeutics, Inc. (OPXAW) for Q2 2016, worth a combined $48K — down 65% from $137K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of OPXAW and 1 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.

The largest buyer was Virtu KCG Holdings, opening a new position worth an estimated $2.43K. The largest seller was E.E. Geduld, exiting entirely with an estimated $4K sold.

  • 4 institutional investors held Opexa Therapeutics, Inc. (OPXAW) as of Q2 2016, down from 5 in Q1 2016.
  • Funds reported $48K of Opexa Therapeutics, Inc. stock for Q2 2016, down 65% quarter-over-quarter.
  • 1 fund opened new Opexa Therapeutics, Inc. positions in Q2 2016 and 2 closed out, a net change of -1 holder.
  • The largest Opexa Therapeutics, Inc. buyer in Q2 2016 was Virtu KCG Holdings, an estimated $2.43K added.
  • The largest Opexa Therapeutics, Inc. seller in Q2 2016 was E.E. Geduld, an estimated $4K sold.

Based on aggregated 13F filings for Q2 2016.